SOMAXON PHARMACEUTICALS

somaxon-pharmaceuticals-logo

Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription therapeutics to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction. The company currently is focusing on in-licensing, developing and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon currently is promoting Silenorยฎ, the first and only nonscheduled prescription medication approved for the treatment of sleep maintenance insomnia. Silenor is now available for prescription in the United States.

#SimilarOrganizations #People #Financial #Website #More

SOMAXON PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2003-01-01

Address:
Solana Beach, California, United States

Country:
United States

Website Url:
http://www.somaxon.com

Total Employee:
251+

Status:
Active

Contact:
858-876-6500

Email Addresses:
[email protected]

Total Funding:
94 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx Euro


Similar Organizations

pacira-pharmaceuticals-logo

Pacira Pharmaceuticals

Pacira Pharmaceuticals is a specialty pharmaceutical company dedicated to postsurgical innovation.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.


Current Advisors List

erle-t-mast_image

Erle T. Mast Board of Directors @ Somaxon Pharmaceuticals
Board_member

not_available_image

Kenneth M. Cohen Co-founded @ Somaxon Pharmaceuticals
Board_member

Current Employees Featured

richard-pascoe_image

Richard Pascoe
Richard Pascoe CEO @ Somaxon Pharmaceuticals
CEO

Founder


not_available_image

Susan Dubรฉ

Stock Details


Company's stock symbol is NASDAQ:SOMX

Investors List

prospect-venture-partners_image

Prospect Venture Partners

Prospect Venture Partners investment in Post-IPO Equity - Somaxon Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Post-IPO Equity - Somaxon Pharmaceuticals

domain-associates_image

Domain Associates

Domain Associates investment in Post-IPO Equity - Somaxon Pharmaceuticals

tavistock-life-sciences_image

Tavistock Life Sciences

Tavistock Life Sciences investment in Post-IPO Equity - Somaxon Pharmaceuticals

scale-venture-partners_image

Scale Venture Partners

Scale Venture Partners investment in Post-IPO Equity - Somaxon Pharmaceuticals

montreaux-equity-partners_image

Montreux Equity Partners

Montreux Equity Partners investment in Post-IPO Equity - Somaxon Pharmaceuticals

prospect-venture-partners_image

Prospect Venture Partners

Prospect Venture Partners investment in Series C - Somaxon Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series C - Somaxon Pharmaceuticals

domain-associates_image

Domain Associates

Domain Associates investment in Series C - Somaxon Pharmaceuticals

cdib-ventures_image

CDIB BioScience Ventures

CDIB BioScience Ventures investment in Series C - Somaxon Pharmaceuticals

Official Site Inspections

http://www.somaxon.com

  • Host name: 173-198-247-252.static.as40244.net
  • IP address: 173.198.247.252
  • Location: Latham United States
  • Latitude: 42.747
  • Longitude: -73.7527
  • Metro Code: 532
  • Timezone: America/New_York
  • Postal: 12110

Loading ...

More informations about "Somaxon Pharmaceuticals" on Search Engine